A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA)

Grant

Date/time Interval

  • April 15, 2020 - July 31, 2023

    • Awarded By

    Total Award Amount

  • 12000.00

    • Direct Costs

  • 9231.00

    • Sponsor Award Id

    • Contributor

  • Emily Smitherman   Investigator  
  • Matthew Stoll   Investigator  
  • Melissa Mannion   Principal Investigator  
  • Peter Weiser   Investigator  
  • Randy Cron MD, PhD   Investigator